Fuji Pharma Company Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fuji Pharma Company Limited with three other
companies in this sector in Japan:
JCR Pharmaceuticals Co., Ltd.
sales of 16.86 billion Japanese Yen [US$162.99 million]
of which 98%
was Pharmaceutical Business),
Daito Pharmaceutical Company Limited
(34.06 billion Japanese Yen [US$329.35 million]
Taiko Pharmaceutical Company., Limited
(8.98 billion Japanese Yen [US$86.82 million]
of which 64%
was Medicine Goods).
Fuji Pharma Company Limited reported sales of ¥31.68 billion (US$306.35 million)
September of 2015.
increase of 8.4%
versus 2014, when the company's sales were ¥29.22 billion.
This was the third consecutive year of growth at Fuji Pharma Company Limited.